Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Sale of 25,000 IBRX shares, $268.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | ImmunityBio, Inc. (IBRX) | Sale | 25,000 | $268.8K |
| Jun 27, 2026 | ImmunityBio, Inc. (IBRX) | Sale | 25,000 | $196.9K |
| Jun 5, 2026 | ImmunityBio, Inc. (IBRX) | Sale | 23,033 | $165.3K |
| Feb 27, 2026 | ImmunityBio, Inc. (IBRX) | Sale | 75,000 | $900.8K |
| Feb 25, 2026 | ImmunityBio, Inc. (IBRX) | Sale | 10,000 | $92.5K |
| Jan 22, 2026 | ImmunityBio, Inc. (IBRX) | Sale | 76,967 | $503.4K |
| Feb 25, 2025 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 15,243 | n/a |
| Jan 24, 2025 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 110,020 | $219.9K |
| Jun 24, 2024 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 50,000 | n/a |
| Feb 26, 2024 | ImmunityBio, Inc. (IBRX) | Grant/Award | 45,731 | n/a |